Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3,326,196 | $682,253,213 | $4,583,307 | $705,762,495 |
| - Cash | $526,247 | $77,161,000 | $392,495 | $64,502,000 |
| + Debt | $339,192 | $50,223,000 | $246,806 | $44,536,000 |
| Enterprise Value | $3,139,141 | $655,315,213 | $4,437,619 | $685,796,495 |
| Revenue | $568,748 | $551,478 | $552,131 | – |
| % Growth | 3.1% | -0.1% | – | – |
| Gross Profit | $314,663 | $301,683 | $316,912 | – |
| % Margin | 55.3% | 54.7% | 57.4% | – |
| EBITDA | $135,137 | $83,765 | $131,703 | – |
| % Margin | 23.8% | 15.2% | 23.9% | – |
| Net Income | $81,665 | $41,329 | $75,589 | – |
| % Margin | 14.4% | 7.5% | 13.7% | – |
| EPS Diluted | 0.36 | 0.18 | 0.33 | – |
| % Growth | 100% | -45.5% | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |